53 related articles for article (PubMed ID: 17073778)
1. Selectivity improvement of an azole inhibitor of CYP707A by replacing the monosubstituted azole with a disubstituted azole.
Todoroki Y; Naiki K; Aoyama H; Shirakura M; Ueno K; Mizutani M; Hirai N
Bioorg Med Chem Lett; 2010 Sep; 20(18):5506-9. PubMed ID: 20692835
[TBL] [Abstract][Full Text] [Related]
2. Investigating Structural Property Relationships to Enable Repurposing of Pharmaceuticals as Zinc Ionophores.
Kavanagh O; Elmes R; O'Sullivan F; Farragher J; Robinson S; Walker G
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959313
[TBL] [Abstract][Full Text] [Related]
3. Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors.
Hull DO; Bajrami B; Jansson I; Schenkman JB; Rusling JF
Anal Chem; 2009 Jan; 81(2):716-24. PubMed ID: 19099359
[TBL] [Abstract][Full Text] [Related]
4. Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.
Nath A; Fernández C; Lampe JN; Atkins WM
Arch Biochem Biophys; 2008 Jun; 474(1):198-204. PubMed ID: 18395506
[TBL] [Abstract][Full Text] [Related]
5. Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes.
Verras A; Kuntz ID; Ortiz de Montellano PR
J Med Chem; 2004 Jul; 47(14):3572-9. PubMed ID: 15214784
[TBL] [Abstract][Full Text] [Related]
6. EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme.
Ogura H; Nishida CR; Hoch UR; Perera R; Dawson JH; Ortiz de Montellano PR
Biochemistry; 2004 Nov; 43(46):14712-21. PubMed ID: 15544342
[TBL] [Abstract][Full Text] [Related]
7. Resonance Raman scattering of cytochrome P450 BM3 and effect of imidazole inhibitors.
Smith SJ; Munro AW; Smith WE
Biopolymers; 2003 Dec; 70(4):620-7. PubMed ID: 14648772
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
9. Protein dynamics and imidazole binding in cytochrome P450 enzymes.
Verras A; Ortiz de Montellano PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778
[TBL] [Abstract][Full Text] [Related]
10. Cytochromes P450 and drug discovery.
Lamb DC; Waterman MR; Kelly SL; Guengerich FP
Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
Haining RL; Nichols-Haining M
Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
